Owen Hughes is Director of PARDES BIOSCIENCES, INC.. Currently has a direct ownership of 52,500 shares of PRDS, which is worth approximately $0. The most recent transaction as insider was on Dec 23, 2021, when has been sold 52,500 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.5K
0% 3M change
0% 12M change
Total Value Held $0

Owen Hughes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2021
BUY
Conversion of derivative security
-
52,500 Added 50.0%
52,500 Class A Common Stock

Also insider at

CGEM
Cullinan Oncology, Inc. Healthcare
RDUS
Radius Health, Inc. Healthcare
TBIO
Translate Bio, Inc. Healthcare
IKNA
Ikena Oncology, Inc. Healthcare
XOMA
XOMA Corp Healthcare
CCCC
C4 Therapeutics, Inc. Healthcare
OH

Owen Hughes

Director
Boston, MA

Track Institutional and Insider Activities on PRDS

Follow PARDES BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRDS shares.

Notify only if

Insider Trading

Get notified when an Pardes Biosciences, Inc. insider buys or sells PRDS shares.

Notify only if

News

Receive news related to PARDES BIOSCIENCES, INC.

Track Activities on PRDS